Author response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
Neurology. 2019 Jan 8;92(2):110-111.
doi: 10.1212/WNL.0000000000006735.